Expressions of SH3BP5, LMO3, and SNAP25 in diffuse large B‐cell lymphoma cells and their association with clinical features

Diffuse large B‐cell lymphoma (DLBCL) is clinicopathologically and genetically heterogeneous with variable clinical outcomes. We previously identified signature genes overexpressed in CD5‐positive (CD5(+)) DLBCL, which is a poor prognostic subgroup of DLBCL. To elucidate the clinical significance of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Med
Prif Awduron: Kobayashi, Kyoko, Yamaguchi, Motoko, Miyazaki, Kana, Imai, Hiroshi, Yokoe, Kaori, Ono, Ryoichi, Nosaka, Tetsuya, Katayama, Naoyuki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2016
Pynciau:
Clinical Cancer Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4873606/
https://ncbi.nlm.nih.gov/pubmed/27184832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.753
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg